Literature DB >> 1534215

Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli.

A Witte1, G Wanner, M Sulzner, W Lubitz.   

Abstract

Expression of cloned gene E of bacteriophage PhiX174 induces lysis by formation of a transmembrane tunnel structure in the cell envelope of Escherichia coli. Ultrastructural studies of the location of the lysis tunnel indicate that it is preferentially located at the septum or at polar regions of the cell. Furthermore, the diameter and shape of individual tunnel structures vary greatly indicating that its structure is not rigid. Apparently, the contours of individual lysis tunnels are determined by enlarged meshes in the peptidoglycan net and the force produced at its orifice, by the outflow of cytoplasmic content. Once the tunnel is formed the driving force for the lysis process is the osmotic pressure difference between cytoplasm and medium. During the lysis process areas of the cytoplasmic membrane which are not tightly attached to the envelope are extended inward by the negative pressure produced during lysis. After cell lysis external medium can diffuse through the lysis tunnel filling the inner cell space of the still rigid bacterial ghosts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534215     DOI: 10.1007/bf00248685

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  34 in total

Review 1.  The 'Bayer bridges' confronted with results from improved electron microscopy methods.

Authors:  E Kellenberger
Journal:  Mol Microbiol       Date:  1990-05       Impact factor: 3.501

2.  Overlapping genes in bacteriophage phiX174.

Authors:  B G Barrell; G M Air; C A Hutchison
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

3.  Regulation of cell division in E. coli.

Authors:  J Lutkenhaus
Journal:  Trends Genet       Date:  1990-01       Impact factor: 11.639

4.  Phi X174 protein E-mediated lysis of Escherichia coli.

Authors:  A Witte; U Bläsi; G Halfmann; M Szostak; G Wanner; W Lubitz
Journal:  Biochimie       Date:  1990 Feb-Mar       Impact factor: 4.079

5.  Purification of F1F0 H(+)-ATPase from Escherichia coli.

Authors:  R H Fillingame; D L Foster
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Lytic action of cloned phi X174 gene E.

Authors:  K D Young; R Young
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

7.  The process of infection with bacteriophage phi-X174. X. Mutations in a phi-X Lysis gene.

Authors:  C A Hutchison; R L Sinsheimer
Journal:  J Mol Biol       Date:  1966-07       Impact factor: 5.469

8.  Lysis of Escherichia coli after infection with phiX174 depends on the regulation of the cellular autolytic system.

Authors:  W Lubitz; G Halfmann; R Plapp
Journal:  J Gen Microbiol       Date:  1984-05

9.  Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli.

Authors:  A Witte; W Lubitz
Journal:  Eur J Biochem       Date:  1989-03-15

10.  In vitro translocation of bacterial proteins across the plasma membrane of Escherichia coli.

Authors:  M Müller; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  40 in total

1.  Online monitoring of Escherichia coli ghost production.

Authors:  W Haidinger; M P Szostak; W Jechlinger; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

2.  Generation of Vibrio anguillarum ghost by coexpression of PhiX 174 lysis E gene and staphylococcal nuclease A gene.

Authors:  Se Ryun Kwon; Yue Jai Kang; Dong Jin Lee; Eun Hye Lee; Yoon Kwon Nam; Sung Koo Kim; Ki Hong Kim
Journal:  Mol Biotechnol       Date:  2009-02-04       Impact factor: 2.695

Review 3.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

Review 4.  Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors:  Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

5.  Attenuation of bacterial virulence by quorum sensing-regulated lysis.

Authors:  Anisia J Silva; Jorge A Benitez; Jian-He Wu
Journal:  J Biotechnol       Date:  2010-07-29       Impact factor: 3.307

6.  Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.

Authors:  Mingming Hu; Yanhe Zhang; Fang Xie; Gang Li; Jianjun Li; Wei Si; Siguo Liu; Shouping Hu; Zhuo Zhang; Nan Shen; Chunlai Wang
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

7.  Cell-cycle progress in obligate predatory bacteria is dependent upon sequential sensing of prey recognition and prey quality cues.

Authors:  Or Rotem; Zohar Pasternak; Eyal Shimoni; Eduard Belausov; Ziv Porat; Shmuel Pietrokovski; Edouard Jurkevitch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-20       Impact factor: 11.205

8.  Hybrid biosynthetic gene therapy vector development and dual engineering capacity.

Authors:  Charles H Jones; Anitha Ravikrishnan; Mingfu Chen; Ryan Reddinger; Mahmoud Kamal Ahmadi; Snehal Rane; Anders P Hakansson; Blaine A Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

9.  Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Authors:  Diana Groza; Sebastian Gehrig; Pavol Kudela; Martin Holcmann; Christine Pirker; Carina Dinhof; Hemma H Schueffl; Marek Sramko; Julia Hoebart; Fatih Alioglu; Michael Grusch; Manfred Ogris; Werner Lubitz; Bernhard K Keppler; Irena Pashkunova-Martic; Christian R Kowol; Maria Sibilia; Walter Berger; Petra Heffeter
Journal:  Oncoimmunology       Date:  2018-02-16       Impact factor: 8.110

10.  Characterization of cell lysis in Pseudomonas putida induced upon expression of heterologous killing genes.

Authors:  M C Ronchel; L Molina; A Witte; W Lutbiz; S Molin; J L Ramos; C Ramos
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.